Appian provides low-code automation platform that accelerates the creation of business applications, enabling its customers to automate their business. The company's platform automates the creation of forms, data flows, records, reports and other software elements that would otherwise need to be manually coded. The company'snSelf-Assembling Interface Layer technology ensures that applications developed on its platform can be deployed across a range of mobile and desktop devices, including desktop web browsers, tablets and mobile phones. The company's platform can be deployed in the cloud or on-premises, with organizations able to access the same functionality and data sources in various cases.

Colony Bankcorp is a bank holding company. Through its subsidiary, Colony Bank (the Bank), the company is engaged in providing banking products and services to commercial and consumer customers in its markets. The company's product line includes, among other things, loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, commercial loans, agri-business and production loans, residential mortgage loans, home equity loans, consumer loans and a variety of demand, savings and time deposit products. The company also provides internet banking services, electronic bill payment services, safe deposit box rentals, and telephone banking.

Cue Biopharma is a biopharmaceutical company engaged in designing and developing a proprietary class of biologic product candidates engineered to selectively modulate the human immune system. The company's Immuno-STAT? (Selective Targeting and Alteration of T Cells) platform enables the company to engineer product candidates that it calls Immuno-STATs? or Immuno-STAT biologics? that directly engage with and direct the activity of antigen specific T cells in a patient's body through a singular molecular framework.

Evelo Biosciences is discovering and developing therapies designed to engage immune cells in the small intestine to drive therapeutic immune effects throughout the body for the treatment of inflammatory diseases and cancers. The company is developing monoclonal microbials, a modality of oral biologic medicines. The company initiates a clinical trial of its monoclonal microbial candidate in inflammatory diseases, EDP1066 and initiates a clinical trial for its inflammation candidate, EDP1815. The company is developing monoclonal microbial therapies in oncology. The company initiates its clinical trial of its oncology product candidate, EDP1503 in combination with KEYTRUDA? (pembrolizumab) in various oncology indications.

Insight Enterprises is a provider of digital technology, cloud/data center optimization, connected workforce, and supply chain optimization solutions and services. The company is organized in the following three operating segments, which are primarily defined by their related geographies: North America; Europe, Middle East and Africa (EMEA); and Asia-Pacific (APAC). The company's offerings in North America and certain countries in EMEA and APAC include a suite of information technology hardware, software and services solutions. The company's offerings in the remainder of its EMEA and APAC segments are primarily software and certain software-related services.

Kingsway Financial Services is a holding company. Through its subsidiaries, Co. operates as a merchant bank engaged in the property and casualty insurance business. Co. operates three segments: Insurance Underwriting, which markets automobile insurance products that provide coverage in three main areas: liability, accident benefits and physical damage; Insurance Services, which includes IWS Acquisition Corporation, a licensed motor vehicle service agreement company, and Trinity Warranty Solutions LLC, a provider of warranty products and maintenance support; and Leased Real Estate, which includes Co.'s subsidiary, CMC Industries, Inc., that owns a parcel of real property located in Texas.

NGM Biopharmaceuticals is a biopharmaceutical company. The company is focused on the following programs: Aldafermin, which is for the treatment of non-alcoholic steatohepatitis (NASH); NGM313 (MK-3655), which is for the treatment of NASH and type 2 diabetes; NGM120, which is designed to block the effects of elevated growth differentiation factor 15 levels on cancer anorexia/cachexia syndrome, and, possibly, tumors; NGM217, which is designed to restore pancreatic islet function and increase insulin production in patients with diabetes; NGM621, which is designed to decrease levels of this protein implicated in the dry form of AMD; and NGM395, which is for the treatment of metabolic syndrome.

Northrim BanCorp is a bank holding company. The company's direct wholly-owned subsidiaries include: Northrim Bank, which operates a factoring business through its subsidiary, Northrim Funding Services, and also provides various commercial and consumer loan and deposit products, investment products, and electronic banking services over the Internet; Northrim Investment Services Company, which owns Pacific Wealth Advisors, LLC, an investment advisory, trust, and wealth management business; and Northrim Statutory Trust 2, which facilitates a trust preferred securities offering by the company The company also originates one-to-four family residential mortgages throughout Alaska which it sells to the secondary market.

Old Republic International is a holding company engaged in the business of insurance underwriting and related services. Through its regulated insurance company subsidiaries, the company conducts its operations in three main segments: General Insurance Group, which is a commercial lines insurance business focused on liability insurance coverages; Title Insurance Group, which consists mainly of the issuance of policies to real estate purchasers and investors based upon searches of the public records, which contain information concerning interests in real property; and the Republic Financial Indemnity Group Run-off Business, which consists of mortgage guaranty and consumer credit indemnity operations.

Sensient Technologies is a manufacturer and marketer of colors, flavors and fragrances. The company's three reportable segments are: Flavors & Fragrances Group, which develops, manufactures, and supplies flavor and fragrance systems for the food, beverage, personal care, and household-products industries; Color Group, which provides natural and synthetic color systems for use in foods, beverages, pharmaceuticals, and nutraceuticals, colors and other ingredients for cosmetics; and Asia Pacific Group, which provides a range of products from its Flavors & Fragrances Group and Color Group, as well as products developed by regional technical teams to appeal to local preferences.

Six Flags Entertainment is a theme park operator and also an operator of waterparks. The company's parks provide a selection of thrill rides, water attractions, themed areas, concerts and shows, restaurants, game venues and retail outlets. The company holds licenses for theme park usage of certain Warner Bros. and DC Comics characters throughout the U.S. (except the Las Vegas metropolitan area), Canada, Mexico and other countries. The company's licenses include the right to sell merchandise featuring the characters at the parks, and to use the characters in its advertising, as walk-around characters and in theming for rides, attractions and retail outlets.